.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Farmers Insurance
Citi
McKinsey
QuintilesIMS
Teva
Boehringer Ingelheim
Mallinckrodt
Medtronic

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,747,896

« Back to Dashboard

Which drugs does patent 8,747,896 protect, and when does it expire?


Patent 8,747,896 protects SITAVIG and is included in one NDA.

This patent has twenty-six patent family members in twenty-four countries.

Summary for Patent: 8,747,896

Title:Mucosal bioadhesive slow release carrier for delivering active principles
Abstract: A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This bioadhesive carrier contains a diluent, an alkali metal alkylsulfate, a binding agent, at least one bioadhesive polymer and at least one sustained release polymer, as well as a method for its preparation.
Inventor(s): Costantini; Dominique (Paris, FR), Lemarchand; Caroline (Paris, FR)
Assignee: BioAlliance Pharma (Paris, FR)
Application Number:13/565,653
Patent Claim Types:
see list of patent claims
Formulation; Delivery; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Epi Hlth
SITAVIG
acyclovir
TABLET;BUCCAL203791-001Apr 12, 2013RXYesYes► Subscribe► SubscribeY TREATMENT OF HERPES LABIALIS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,747,896

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
06290480Mar 24, 2006

Non-Orange Book Patents for Patent: 8,747,896

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,211,466Mucosal bioadhesive slow release carrier for delivering active principles► Subscribe
8,791,127Mucosal bioadhesive slow release carrier for delivering active principles► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,747,896

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina060085► Subscribe
Austria446743► Subscribe
Australia2007231029► Subscribe
BrazilPI0709057► Subscribe
Canada2647123► Subscribe
China101410092► Subscribe
Cyprus1109723► Subscribe
Germany602007002996► Subscribe
Denmark1998750► Subscribe
European Patent Office1837020► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
Dow
Covington
Harvard Business School
Deloitte
McKesson
Cantor Fitzgerald
Argus Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot